A Therapeutic Vaccine For Advanced Prostate Cancer

Provenge, the first therapeutic vaccine, has been approved by the FDA for metastatic prostate cancer and will be available within the next year to patients who meet the criteria for advanced prostate cancer. The vaccine is different from preventive vaccines which are given to stimulate the immune system to protect people from getting a disease. A therapeutic vaccine is given to help boost the body’s immune system in order to fight specific cancer cells – in this case prostate cancer cells.

Ipilimumab Raises the Hopes of Advanced Melanoma Patients

As one of the deadliest cancers in the world, melanoma can rapidly spread from the skin to important internal organs, such as the brain. Bristol-Myers Squibb has been developing a new drug, ipilimumab, to treat patients who suffer from the advanced stages of this disease.

Ipilimumab aids the activation of the immune system’s T-cells in order to fight the cancer. The results of a study that analyze the effects of the drug on advanced melanoma patients are very impressive:

Ipilimumab Raises the Hopes of Advanced Melanoma Patients

As one of the deadliest cancers in the world, melanoma can rapidly spread from the skin to important internal organs, such as the brain. Bristol-Myers Squibb has been developing a new drug, ipilimumab, to treat patients who suffer from the advanced stages of this disease.

Ipilimumab aids the activation of the immune system’s T-cells in order to fight the cancer. The results of a study that analyze the effects of the drug on advanced melanoma patients are very impressive: